Diagnostic Criteria in the Diagnosis of Spinal Spondyloarthropathies in Patients With Chronic Low Back Pain (Study P05320)(COMPLETED)
NCT ID: NCT00726765
Last Updated: 2016-01-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1090 participants
OBSERVATIONAL
2008-06-30
2010-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Biomarkers in Early-stage Spondyloarthritis
NCT04095169
Ankylosing Spondylitis and Spondyloarthritis Evaluation Tool Study
NCT01302730
Description of Spondylarthritis and Validation of ASAS Criteria in West Indian Patients Seen in Consultation of Rheumatology.
NCT03564743
Severity Over Time of Early Forms of Spondyloarthritis
NCT06261931
Reliability of IBP Criteria & Activity Scores in Patients With AxSpA
NCT05327140
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Referral Strategy 1
Patient meets at least one of the following three criteria:
1. Inflammatory back pain
2. Human leukocyte antigen B27 (HLA-B27)
3. Sacroiliitis demonstrated by imaging (X-ray, magnetic resonance imagining \[MRI\], bone scan \[if previously available\])
No interventions assigned to this group
Referral Strategy 2
Patient meets at least two of the following six criteria:
1. Inflammatory back pain
2. HLA-B27
3. Sacroiliitis (on imaging)
4. Family history of AS
5. Good response of back pain to nonsteroidal anti-inflammatory drugs (NSAIDs)
6. Known Extra Articular Manifestations (Uveitis, Iridocyclitis, Psoriasis, Inflammatory Bowel Disease)
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* A subject must be willing to give written informed consent and be able to adhere to visit schedules.
Exclusion Criteria
* Any clinically significant condition or situation, other than the condition being studied, that, in the opinion of the investigator, would interfere with the study evaluations or optimal participation in the study.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Merck Sharp & Dohme LLC
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
References
Explore related publications, articles, or registry entries linked to this study.
Sieper J, Srinivasan S, Zamani O, Mielants H, Choquette D, Pavelka K, Loft AG, Geher P, Danda D, Reitblat T, Cantini F, Ancuta C, Erdes S, Raffayova H, Keat A, Gaston JS, Praprotnik S, Vastesaeger N. Comparison of two referral strategies for diagnosis of axial spondyloarthritis: the Recognising and Diagnosing Ankylosing Spondylitis Reliably (RADAR) study. Ann Rheum Dis. 2013 Oct;72(10):1621-7. doi: 10.1136/annrheumdis-2012-201777. Epub 2012 Oct 13.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P05320
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.